Fig. 2From: Three year survival among patients with aids-related Kaposi sarcoma treated with chemotherapy and combination antiretroviral therapy at Moi teaching and referral hospital, KenyaThree-year survival curves in patients who responded to chemotherapy after the first 6 weeks and those who had persistent disease (HR 1.212 (0.257, 5.716); p = 0.8018])Back to article page